Free Trial
LON:BVXP

Bioventix 3/31/2025 Earnings Report

Bioventix logo
GBX 1,700 0.00 (0.00%)
As of 05/15/2026 12:25 PM Eastern

Bioventix EPS Results

Actual EPS
GBX 72.27
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Bioventix Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Bioventix Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Bioventix Earnings Headlines

Peter Harrison Spends UK£39k On Bioventix Stock
5 steps to bulletproof every trade
Most traders skip a critical step before entering a position - and it costs them. The Safe Trade Options Formula is a free 5-part framework built to help you evaluate every trade before you place it. The formula covers five straightforward steps designed to filter out risky setups and give you a more disciplined approach to options trading.tc pixel
See More Bioventix Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Bioventix? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bioventix and other key companies, straight to your email.

About Bioventix

Bioventix (LON:BVXP) creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.

View Bioventix Profile